24/7 Market News Snapshot 26 December, 2024 – Hoth Therapeutics, Inc. Common Stock (NASDAQ:HOTH)

December 26, 2024

DENVER, Colo., 26 December, 2024 (247marketnews.com) – (NASDAQ:HOTH) are discussed in this article.
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a leading biopharmaceutical firm focused on developing innovative therapies, has recently announced an exclusive patent license agreement with the U.S. Department of Veterans Affairs (VA) and Emory University. This strategic collaboration signifies a significant advancement in the company’s efforts to combat obesity and related health issues through access to a unique patent portfolio centered on the application of Glial Cell Line-Derived Neurotrophic Factor. This revolutionary technology aims to enhance treatment modalities for obesity, highlighting Hoth’s commitment to improving healthcare solutions.

In conjunction with this announcement, Hoth’s stock is on an upward trajectory, trading at $0.806—a gain of approximately 2.41% from its previous close of $0.787. This rise, coupled with a robust trading volume of 6.74 million shares, reflects heightened investor interest and a positive market sentiment regarding the company’s prospects. The current price movement suggests that important support levels may be established around $0.80, with potential resistance identified near $0.85. Investors are advised to keep a close watch on these dynamics, as sustained buying could further amplify bullish trends.

Robb Knie, CEO of Hoth Therapeutics, expressed his excitement about the new partnership, emphasizing the shared goal with the VA and Emory to transform scientific advancements into market-ready solutions to enhance the quality of life for patients battling obesity. The company is also enriching its intellectual property portfolio by acquiring additional provisional patent protections for its lead therapeutic, HT-001, thereby augmenting its potential in cancer therapeutics. Through these critical collaborations and developments, Hoth Therapeutics remains dedicated to addressing significant unmet medical needs while maintaining high development standards.

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.